7ZL3
Signal peptide mimicry primes Sec61 for client-selective inhibition
Summary for 7ZL3
| Entry DOI | 10.2210/pdb7zl3/pdb |
| EMDB information | 14776 3068 |
| Descriptor | Protein transport protein Sec61 subunit alpha, Protein transport protein Sec61 subunit gamma, Protein transport protein Sec61 subunit beta, ... (4 entities in total) |
| Functional Keywords | sec61 translocon, cryoem, membrane protein, protein biogenesis |
| Biological source | Ovis aries (sheep) More |
| Total number of polymer chains | 4 |
| Total formula weight | 63374.41 |
| Authors | Rehan, S.,Paavilainen O, V. (deposition date: 2022-04-13, release date: 2023-03-22, Last modification date: 2023-11-15) |
| Primary citation | Rehan, S.,Tranter, D.,Sharp, P.P.,Craven, G.B.,Lowe, E.,Anderl, J.L.,Muchamuel, T.,Abrishami, V.,Kuivanen, S.,Wenzell, N.A.,Jennings, A.,Kalyanaraman, C.,Strandin, T.,Javanainen, M.,Vapalahti, O.,Jacobson, M.P.,McMinn, D.,Kirk, C.J.,Huiskonen, J.T.,Taunton, J.,Paavilainen, V.O. Signal peptide mimicry primes Sec61 for client-selective inhibition. Nat.Chem.Biol., 19:1054-1062, 2023 Cited by PubMed Abstract: Preventing the biogenesis of disease-relevant proteins is an attractive therapeutic strategy, but attempts to target essential protein biogenesis factors have been hampered by excessive toxicity. Here we describe KZR-8445, a cyclic depsipeptide that targets the Sec61 translocon and selectively disrupts secretory and membrane protein biogenesis in a signal peptide-dependent manner. KZR-8445 potently inhibits the secretion of pro-inflammatory cytokines in primary immune cells and is highly efficacious in a mouse model of rheumatoid arthritis. A cryogenic electron microscopy structure reveals that KZR-8445 occupies the fully opened Se61 lateral gate and blocks access to the lumenal plug domain. KZR-8445 binding stabilizes the lateral gate helices in a manner that traps select signal peptides in the Sec61 channel and prevents their movement into the lipid bilayer. Our results establish a framework for the structure-guided discovery of novel therapeutics that selectively modulate Sec61-mediated protein biogenesis. PubMed: 37169961DOI: 10.1038/s41589-023-01326-1 PDB entries with the same primary citation |
| Experimental method | ELECTRON MICROSCOPY (3.2 Å) |
Structure validation
Download full validation report






